Evidence map›Paper›PMID 41220881›Full record

ArticleJournal of multidisciplinary healthcare2025

Assessing Risk Factors for Visceral Leishmaniasis Outbreak in South Omo Zone, Southern Ethiopia: Implications for Tailored Intervention Strategies.

Chuchu Churko, Alemayehu Bekele Kassahun, Tsegaye Yohanes, Zerihun Zerdo, Tamiru Shibiru Degaga, Tadiwos Hailu Zewdie, Belachew Bokicho, Adugna Tamiru, Fikre Seife, Zeyede Kebede and 5 more

Abstract read
In one paragraph

Article in Journal of multidisciplinary healthcare, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Chuchu ChurkoCollaborative Research and Training Center for Neglected Tropical Diseases, Arba Minch University, Arba Minch, South Ethiopia Region, Ethiopia.ORCID 0000-0002-9132-9471
Alemayehu Bekele KassahunCollaborative Research and Training Center for Neglected Tropical Diseases, Arba Minch University, Arba Minch, South Ethiopia Region, Ethiopia.ORCID 0000-0001-8341-4855
Tsegaye YohanesDepartment of Medical Laboratory, Arba Minch University, Arba Minch, South Ethiopia Region, Ethiopia.
Zerihun ZerdoDepartment of Medical Laboratory, Arba Minch University, Arba Minch, South Ethiopia Region, Ethiopia.
Tamiru Shibiru DegagaDepartment of Internal Medicine, Arba Minch University, Arba Minch, South Ethiopia Region, Ethiopia.ORCID 0000-0002-0976-5558
Tadiwos Hailu ZewdieDepartment of Internal Medicine, Arba Minch University, Arba Minch, South Ethiopia Region, Ethiopia.
Belachew BokichoRegional Health Bureau, Jinka, South Ethiopia Region, Ethiopia.
Adugna TamiruNeglected Tropical Diseases Team, Ministry of Health, Addis Ababa, Ethiopia.
Fikre SeifeNeglected Tropical Diseases Team, Ministry of Health, Addis Ababa, Ethiopia.ORCID 0000-0001-7417-3877
Zeyede KebedeWHO Country Office, Addis Ababa, Ethiopia.
Nigus ManayeWHO Country Office, Addis Ababa, Ethiopia.
Abate Mulugeta BeshahWHO African Regional Office, Brazzaville, Republic of the Congo.
Fekadu MasseboDepartment of Biology, Arba Minch University, Arba Minch, South Ethiopia Region, Ethiopia.
Henock Bekele KetoWHO Country Office, Addis Ababa, Ethiopia.
Abinet GebremickaelCollaborative Research and Training Center for Neglected Tropical Diseases, Arba Minch University, Arba Minch, South Ethiopia Region, Ethiopia.ORCID 0000-0002-2179-7499

Funding

World Health Organization 001
6 · The paper itself

Abstract

Background: Visceral leishmaniasis (VL) is a severe, life-threatening public health concern in Ethiopia. Since early 2022, the outbreak of VL in the South Omo Zone, particularly among pastoralist communities, has resulted in multiple deaths. Objective: To assess the risk factors contributing to the VL outbreak in South Omo Zone, southern Ethiopia. Methods: A mixed-method study was conducted in Hammer, Nyangatom, and Selamago districts (areas with the highest case load). The study included a stakeholder consultative workshop and qualitative interviews with health workers, community leaders, and caregivers. A matched case-control study was also performed, and conditional logistic regression was used to analyze quantitative data. Findings: The stakeholder consultation revealed 64 challenges linked to the outbreak. The top-ranked challenge was the high non-medical cost of VL diagnosis and treatment, followed by limited government and stakeholder commitment. Notably, the absence of governmental structure in the Mursi area (Selamago district) was identified as a significant barrier despite being ranked 11th. Qualitative data highlighted additional challenges: poor transportation, distant treatment services, low awareness, cultural treatment practices, and lengthy therapy duration. Quantitatively, family history of VL was a significant risk factor (AOR = 2.91, 95% CI: 1.73-4.87), while VL cases were more likely to have good knowledge of the disease than controls (AOR = 6.6, 95% CI: 2.34-18.42). Conclusion: The findings highlight significant challenges in the control and management of visceral leishmaniasis (VL) in South Omo Zone, including high non-medical costs of care, limited government commitment, inadequate outbreak preparedness, and shortages of trained providers. Prioritized strategies emphasized strengthening health systems, mobilizing resources, and engaging political and community leaders. Addressing systemic gaps and strengthening community-based interventions are essential for effective VL outbreak control and timely treatment.

Indexed as

Ethiopiaoutbreaksrisk factorsSouth Omo zonevisceral leishmaniasis

Identifiers

PMID41220881
PMCPMC12599221

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.